BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7919963)

  • 1. A low NM23.H1 gene expression identifying high malignancy human melanomas.
    Caligo MA; Grammatico P; Cipollini G; Varesco L; Del Porto G; Bevilacqua G
    Melanoma Res; 1994 Jun; 4(3):179-84. PubMed ID: 7919963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the tumor metastatic suppressor gene in mouse melanoma model: inverse association to metastatic potential.
    Meng L
    J Tongji Med Univ; 1998; 18(1):28-32, 36. PubMed ID: 10806798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between NM23-H1 gene expression and metastasis of human uveal melanoma in an animal model.
    Ma D; Luyten GP; Luider TM; Jager MJ; Niederkorn JY
    Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2293-301. PubMed ID: 8843913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of nm23 protein expression in malignant melanoma. An immunohistochemical study.
    van den Oord JJ; Maes A; Stas M; Nuyts J; De Wever I; De Wolf-Peeters C
    Melanoma Res; 1997 Apr; 7(2):121-8. PubMed ID: 9167178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of metastasis suppressor gene product, nm23 protein, is not inversely correlated with the tumour progression in human malignant melanomas.
    Saitoh K; Takahashi H; Yamamoto M; Kishi H; Parsons PG
    Histopathology; 1996 Dec; 29(6):497-505. PubMed ID: 8971556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression and mutation of NME genes in autologous cultured human melanoma cells with different metastatic potentials.
    Hamby CV; Mendola CE; Potla L; Stafford G; Backer JM
    Biochem Biophys Res Commun; 1995 Jun; 211(2):579-85. PubMed ID: 7794272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of NM23 in human melanoma progression and metastasis.
    Easty DJ; Maung K; Lascu I; Véron M; Fallowfield ME; Hart IR; Bennett DC
    Br J Cancer; 1996 Jul; 74(1):109-14. PubMed ID: 8679442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of NM23 protein in acquired melanocytic nevi, malignant melanoma and metastases of malignant melanoma: an immunohistological assessment in human skin.
    Reichrath J; Seyfried P; Braun R; Müller SM; Baum HP; Bahmer FA
    Dermatology; 1997; 194(2):136-9. PubMed ID: 9094461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the nm23 metastasis-suppressor gene product in skin tumors.
    Kanitakis J; Euvrard S; Bourchany D; Faure M; Claudy A
    J Cutan Pathol; 1997 Mar; 24(3):151-6. PubMed ID: 9085150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The loss of NM23 protein in malignant melanoma predicts lymphatic spread without affecting survival.
    Döme B; Somlai B; Tímár J
    Anticancer Res; 2000; 20(5C):3971-4. PubMed ID: 11268486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppressive role of the metastasis-related nm23-H1 gene in human ovarian carcinomas: association of high messenger RNA expression with lack of lymph node metastasis.
    Viel A; Dall'Agnese L; Canzonieri V; Sopracordevole F; Capozzi E; Carbone A; Visentin MC; Boiocchi M
    Cancer Res; 1995 Jun; 55(12):2645-50. PubMed ID: 7780979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of a catalytically inactive H118Y mutant of nm23-H2 suppresses the metastatic potential of line IV Cl 1 human melanoma cells.
    Hamby CV; Abbi R; Prasad N; Stauffer C; Thomson J; Mendola CE; Sidorov V; Backer JM
    Int J Cancer; 2000 Nov; 88(4):547-53. PubMed ID: 11058869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An immunohistochemical analysis of nm23 gene product expression in uveal melanoma.
    Greco IM; Calvisi G; Ventura L; Cerrito F
    Melanoma Res; 1997 Jun; 7(3):231-6. PubMed ID: 9195562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nm23/nucleoside diphosphate (NDP) kinase expression in human malignant melanomas: significance and implications in tumor biology.
    Bodey B; Bodey B; Gröger AM; Siegel SE; Kaiser HE
    Anticancer Res; 1997; 17(1A):505-11. PubMed ID: 9066703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NM23 expression in metastasis of malignant melanoma is a predictive prognostic parameter correlated with survival.
    Xerri L; Grob JJ; Battyani Z; Gouvernet J; Hassoun J; Bonerandi JJ
    Br J Cancer; 1994 Dec; 70(6):1224-8. PubMed ID: 7981081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of nm23-H1 in uveal melanoma.
    Bakalian S; Marshall JC; Faingold D; Logan P; Antecka E; Burnier MN
    Melanoma Res; 2007 Oct; 17(5):284-90. PubMed ID: 17885583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. nm23--relationship to the metastatic potential of breast carcinoma cell lines, primary human xenografts, and lymph node negative breast carcinoma patients.
    Russell RL; Geisinger KR; Mehta RR; White WL; Shelton B; Kute TE
    Cancer; 1997 Mar; 79(6):1158-65. PubMed ID: 9070493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of Nm23 expression as an independent prognostic indicator in primary thick melanoma.
    Holmes SC; MacKie RM
    J Cutan Pathol; 1996 Aug; 23(4):344-9. PubMed ID: 8864922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical demonstration of the nm23-H1 gene product in human malignant melanoma and Spitz nevi.
    Lee CS; Pirdas A; Lee MW
    Pathology; 1996 Aug; 28(3):220-4. PubMed ID: 8912348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of nm23 in cell lines derived from patients with metastatic renal cell carcinoma.
    Walther MM; Anglard P; Gnarra J; Pozzatti R; Venzon D; de la Rosa A; MacDonald NJ; Steeg PS; Linehan WM
    J Urol; 1995 Jul; 154(1):278-82. PubMed ID: 7776445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.